Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec

BACKGROUND: The 21-gene Breast Recurrence Score (RS) assay, “the assay”, has led to a paradigm shift for patients with hormone receptor-positive, node-negative early breast cancer and is emerging as an important tool to assist physician-patient decisions in foregoing chemotherapy in node-positive pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Saima, Younan, Rami, Patocskai, Erica, Provencher, Louise, Poirier, Brigitte, Sideris, Luca, Dubé, Pierre, Mihalcioiu, Catalin, Chabot-Blanchet, Malorie, Guertin, Marie-Claude, Boileau, Jean-François, Robidoux, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526502/
https://www.ncbi.nlm.nih.gov/pubmed/35830543
http://dx.doi.org/10.1093/oncolo/oyac123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526502/
https://www.ncbi.nlm.nih.gov/pubmed/35830543
http://dx.doi.org/10.1093/oncolo/oyac123

Ejemplares similares